These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 21575805)

  • 21. No. 376-Magnesium Sulphate for Fetal Neuroprotection.
    Magee LA; De Silva DA; Sawchuck D; Synnes A; von Dadelszen P
    J Obstet Gynaecol Can; 2019 Apr; 41(4):505-522. PubMed ID: 30879485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Obstetric interventions beneficial to prematurely delivering newborn babies: antenatal corticostetroids, progesterone, magnesium sulfate.
    Garite TJ; Combs CA
    Clin Perinatol; 2012 Mar; 39(1):33-45. PubMed ID: 22341535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnesium sulfate during anticipated preterm birth for infant neuroprotection.
    Merrill L
    Nurs Womens Health; 2013; 17(1):42-51. PubMed ID: 23399012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus.
    Doyle LW; Crowther CA; Middleton P; Marret S; Rouse D
    Cochrane Database Syst Rev; 2009 Jan; (1):CD004661. PubMed ID: 19160238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maternal obesity and neuroprotective magnesium sulfate.
    McPherson J; Smiley S; Stamilio D
    Am J Obstet Gynecol; 2015 Oct; 213(4):582.e1-6. PubMed ID: 26116874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus.
    Doyle LW; Crowther CA; Middleton P; Marret S
    Cochrane Database Syst Rev; 2007 Jul; (3):CD004661. PubMed ID: 17636771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain lesions in newborns exposed to high-dose magnesium sulfate during preterm labor.
    Mittendorf R; Dammann O; Lee KS
    J Perinatol; 2006 Jan; 26(1):57-63. PubMed ID: 16319938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized controlled trial of magnesium sulfate in women at risk of preterm delivery-neonatal cardiovascular effects.
    Paradisis M; Osborn DA; Evans N; Kluckow M
    J Perinatol; 2012 Sep; 32(9):665-70. PubMed ID: 22094492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SOGC Clinical Practice Guideline. Magnesium sulphate for fetal neuroprotection.
    Magee L; Sawchuck D; Synnes A; von Dadelszen P; ;
    J Obstet Gynaecol Can; 2011 May; 33(5):516-529. PubMed ID: 21639972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. School-age outcomes following a randomized controlled trial of magnesium sulfate for neuroprotection of preterm infants.
    Chollat C; Enser M; Houivet E; Provost D; Bénichou J; Marpeau L; Marret S
    J Pediatr; 2014 Aug; 165(2):398-400.e3. PubMed ID: 24837863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of magnesium sulfate in the prevention of cerebral palsy.
    Scheans P
    Neonatal Netw; 2012; 31(2):121-4. PubMed ID: 22397798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnesium sulfate for preterm neuroprotection.
    Ananth CV; Vintzileos AM
    JAMA; 2004 Feb; 291(8):940; author reply 941. PubMed ID: 14982907
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of antenatal exposure to magnesium sulfate on neuroprotection and mortality in preterm infants: a meta-analysis.
    Costantine MM; Weiner SJ;
    Obstet Gynecol; 2009 Aug; 114(2 Pt 1):354-364. PubMed ID: 19622997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immediate clinical outcomes in preterm neonates receiving antenatal magnesium for neuroprotection.
    Basu SK; Chickajajur V; Lopez V; Bhutada A; Pagala M; Rastogi S
    J Perinat Med; 2011 Aug; 40(2):185-9. PubMed ID: 21834608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants.
    Mittendorf R; Pryde PG; Lee KS
    Am J Obstet Gynecol; 2003 Aug; 189(2):613. PubMed ID: 14524362
    [No Abstract]   [Full Text] [Related]  

  • 36. Magnesium sulfate and cerebral palsy in premature infants.
    Hirtz DG; Nelson K
    Curr Opin Pediatr; 1998 Apr; 10(2):131-7. PubMed ID: 9608889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Magnesium Sulfate and Novel Therapies to Promote Neuroprotection.
    Jameson RA; Bernstein HB
    Clin Perinatol; 2019 Jun; 46(2):187-201. PubMed ID: 31010555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Magnesium sulfate for preterm neuroprotection.
    Mittendorf R; Lee KS; Roizen NJ; Pryde PG
    JAMA; 2004 Feb; 291(8):940-1; author reply 941. PubMed ID: 14982906
    [No Abstract]   [Full Text] [Related]  

  • 39. Magnesium sulfate therapy for the prevention of cerebral palsy in preterm infants: a decision-analytic and economic analysis.
    Cahill AG; Odibo AO; Stout MJ; Grobman WA; Macones GA; Caughey AB
    Am J Obstet Gynecol; 2011 Dec; 205(6):542.e1-7. PubMed ID: 22000669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnesium sulphate and perinatal mortality and morbidity in very-low-birthweight infants born between 24 and 32 weeks of gestation in Japan.
    Ohhashi M; Yoshitomi T; Sumiyoshi K; Kawagoe Y; Satoh S; Sameshima H; Ikenoue T
    Eur J Obstet Gynecol Reprod Biol; 2016 Jun; 201():140-5. PubMed ID: 27131232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.